@Article{,
AUTHOR = {Patrick J. Shenot, J. Ryan Mark},
TITLE = {Intradetrusor onabotulinumtoxinA injection: how I do it},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {20},
YEAR = {2013},
NUMBER = {1},
PAGES = {6649--6655},
URL = {http://www.techscience.com/CJU/v20n1/61650},
ISSN = {1488-5581},
ABSTRACT = {Overactive bladder is a highly prevalent condition that may 
have significant impact on quality of life. This condition 
may be idiopathic or may have a neurogenic etiology. 
Antimuscarinics have long been the preferred agents for 
the treatment of this condition. OnabotulinumtoxinA, 
an injectible agent that prevents presynaptic release of 
acetylcholine at the neuromuscular junction, has emerged 
as an important option in the management of patients 
with urinary incontinence caused by refractory detrusor 
overactivity. This manuscript describes our technique for 
performing utilizing this therapy, describes key equipment 
needed and provides technical tips for avoiding common 
pitfalls.},
DOI = {}
}